Companies: 10,795·Total market cap: $144.5T

bioMérieux S.A.

bioMérieux S.A.

BMXXYOTCHealthcare● Active

$8.43

$-1.72(-16.95%)

Market Cap$9.9B

P/E Ratio—

52W High$14.62

52W Low$7.9075

Avg Volume3K

Open$8.43

Beta0.56

股票排行：Medical - Diagnostics & Research·Healthcare·查看全部市值排行 →

bioMérieux S.A.（BMXXY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BMXXY · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.70Earnings history

PE Ratio (TTM)12.0×PE Ratio deep dive

Revenue (TTM)$8.0BFull revenue history

Dividend Yield1.35%Dividend history

Shares Outstanding1.18BShares outstanding history

Next EarningsTBAEarnings history

探索 bioMérieux S.A. 数据

分析师预测—

营收$3.9B-1.78%

盈利EPS $0.32-13.51%

市盈率12.0×

财务快照

FY 2025Revenue$3.91B▼ 1.78% YoY

202320242025

FY 2025Net Income$381.8M▼ 11.66% YoY

202320242025

FY 2025EPS$0.32▼ 13.51% YoY

202320242025

TTM:Revenue: $8.03BNet Income: $827.8MEPS: $0.70View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

bioMérieux S.A.

$8.43-16.95%$9.9B #2

Astellas Pharma Inc.

$13.50+1.89%$24.2B #3

$5.39-5.27%$14.2B #4

$249.45-7.82%$15.3B #5

$40.63+6.96%$22.9B #6

Straumann Holding AG

$119.16+0.08%$19.0B

股票表现

1D-16.95%

1W-7.36%

1M+6.04%

3M-42.06%

YTD-33.10%

1Y-34.90%

5Y-91.65%

关于 bioMérieux S.A.

CEOPierre Boulud

IPO DateJun 9, 2023

Employees14,147

CountryFR

Websitebiomerieux.com

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers …

Medical - Diagnostics & Research HealthcareOTCADRFR

关于股票概览与关键数据

bioMérieux S.A.（BMXXY）是 Medical - Diagnostics & Research 行业的 Healthcare 类公司，于 Jun 9, 2023 在 OTC 上市。截至最近交易日，BMXXY 股价为 $8.43，市值约为 $9.9B。过去12个月累计回报 -34.90%，年初至今回报 -33.10%。

2025 财年 bioMérieux S.A. 营收 $3.9B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，bioMérieux S.A.（BMXXY）股价为 $8.43，在 OTC 上市，52周区间为 $7.91 – $14.62。

BMXXY 最新股价BMXXY quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议